The aim of the present study was to investigate the effects of Angiotensin II (AngII) and Arginin-Vasopressin (AVP) on contractility of non-pregnant uterus in diabetic Wistar rats and to explore whether one-week administration of Melatonin (MLT) or Ghrelin (GHR) will change the response of diabetic uterine muscle to AngII and AVP. Uterine horns, prepared by the method of isolated tissues were investigated as well as glycemic profile, blood pressure and body weight. The research of smooth muscle contractions was made by a new method of analysis, characterizing in detail the various phases of the myometrial activity.
2 factors in the regulation of the smooth muscle tone. They act in a similar pattern, by activating the inositol-triphosphate signal pathway. Besides the proven contractile effect of Ang II and AVP on the uterine arteries, the myometrium is also sensitive to the effect of these octapeptides (Keskil et al. 1999; Steinwall et al. 2005) .
Diabetes mellitus (DM) comprises a group of metabolic disorders characterized by hyperglycemia due to disturbaces in insulin secretion, insulin action, or both. The persistent hyperglycemia leads to long-term organ damages, thus affecting all the systems in the organism (Abu-El Asrar 2013). Most of the manifested symptoms of DM are related to smooth muscle dysfunction (Stamler et al. 1993) . The etiology of the impaired smooth muscle motility in DM is multifactorial, assuming involvement of oxidative stress, apoptosis, neuronal loss, and accumulation of glycated products (Suzuki et al. 2011; Chang et al. 2012) .
Considering the role of oxidative stress for the development of structural and functional cell damage and the progression of DM, many scientific efforts are directed towards search and application of effective antioxidants (Chatzigeorgiu et al. 2009 ). Such possible antioxidants having a therapeutic potential for treatment of diabetic disorders, are hormones melatonin (MLT) and ghrelin (GHR). In rats with experimentally induced diabetes, it was found that administration of these hormones exerts a protective effect on pancreatic beta-cells mass and function (Vural et al. 2001; Granata et al. 2010 ).
The diabetic changes in Ang II-and AVP-mediated contractile activity of uterus are not enought studied (Falkay et al. 2007; Shpakov et al. 2013) as well as the effect of administration of MLT and GHR on myometrial smooth muscle activity.
The published data about effects of GHR on myometrial activity are controversial.
Some authors found that GHR stimulates rat spontaneous uterine contractions (AlSaif et al. 2015) . On the other hand, Hehir et al. (2008) have reported that GHR has concentrationdependent inhibitory effect on myometrial activity. For the duration of the pregnancy, the 3 highest levels of GHR in serum (measured as total concentration) are detected in the mildgestation period and the lowest -in the last trimester (Hehir et al. 2008) . It was also found that myometrially-produced GHR plays an important role in relaxation in this tissue during pregnancy (O'Brien et al. 2010) . MLT also has significance for the timing and power of uterine contractions. It acts through MTNR1B receptor to increase oxytocin-dependent contractions in end-term pregnancy (Olcese & Beesley 2014) .
The aim of this study is to investigate the effects of Ang II and AVP on myometrial smooth muscle of rats with experimentally induced diabetes and to explore whether one-week administration of MLT or GHR on diabetic rats will change the response of uterine smooth muscle of Ang II and AVP.
Methods:
Animals 32 non-pregnant female Wistar rats, weighting 200-250 g were used. The animals were divided into the following groups: Group 1: controls; Group 2: diabetic animals; Group 3: diabetic animals, treated with MLT; Group 4: diabetic animals treated with GHR. DM was induced by a single intraperitoneal injection of Streptozotocin (STZ) 60 mg/kg bw. STZ was dissolved in cold 0.1M citrate buffer, pH 4.5. 72 hours after STZ administration, only animals with blood glucose levels higher than 16 mmol/l were considered to be diabetic and left in the experiment. The experiment lasted 42 days. In the beginning and in the end of experimental period, body weight, glycated hemoglobin (HbA1c) and blood pressure of the animals were measured. In the end of the experimental period plasma levels of C-peptide were determined. 
Chemicals, drugs and equipment
Ang II, AVP, STZ, MLT and all reagents for preparation of Krebs solution and citrate buffer were purchased from Sigma-Aldrich Chemie GmbH, Germany. GHR was purchased from PolyPeptide Group, Sweden. HbA1c was determined by Glycohemoglobin HbA1-test (HUMAN, Germany). Blood glucose levels were measured by Medisign mm810 glucomer (Empecs Medical Device Co., Ltd., China). The system for non-invasively measuring the blood pressure of rats was purchased from BIOPAC Systems Inc., USA.
Data analysis and statistical processing
The mechanical activity was transformed by mechanical-force sensor, amplified, Obtained data were processed by the statistical program Statistica Version 6.1 (StaSoft, Inc., Tulsa, OK, USA) and presented as mean ± standard error. Statistical analysis was performed using one-way ANOVA and Student t-test to determine significant differences among data groups. A P-value less than or equal to 0.05 was considered to be statistically significant.
Results:
Regarding the amplitude of Ang II -provoked SMCs there were significant differences between contractions from preparations of the different phases as well as the different diabetic groups (Fig.1) . In phase 1 (follicular), all groups of preparations demonstrated significantly higher amplitude compared to those form phase 2 (luteal). The preparations from group 2 responded to Ang II with decreased amplitude compared to the 6 controls (3.62±0.59g vs. 5.80±0.30g in phase 1 and 1.12±0.18g vs. 2.62±0.22g in phase 2). It is interesting that uterine contractions from groups 3 and 4 were with similar amplitudes.
In regard to amplitudes of AVP-induced SMCs, there was similar tendency in the response. Again, in both phases of the estrous cycle, the UH preparations from group 2 developed lower amplitude compared to those of the controls.
The analysis of the integral force of SMC obtained after application of Ang II revealed differences between the control group and the three diabetic groups (Fig. 2) .
During phase 1, AUC of Ang II-influenced contractions of preparations from diabetic groups were almost threefold decreased when compared to controls. In phase 2 this difference fell to twice. It is interesting to note that AUC of Ang II-induced contractions of group 3 showed no differences associated with the phase of estrous cycle (443±35g.s for phase 1 and 434±31g.s for phase 2).
The analysis of AUC of SMCs obtained after administration of AVP, also revealed similarities with AUC of Ang II-mediated contractions. During the phase 2, again preparations from group 2 developed weakest AUC -218±54g.s, preparations from group 3, however, developed contractions with greatest AUC -564±36g.s. During the phase 1, the preparations of control group demonstrated the biggest AUC that was statistically different when compared to AUC of the other groups.
With respect to time-parameters of SMCs (Table 1 ) different results were obtained depending on the phases of the estrous cycle.
During phase 2 the preparations from group 2 and group 3 developed Ang IIprovoked contractions with similar T c , while the contractions from group 4 showed shortest values for this parameter (11±2s). Regaring T hr and T chr , groups 3 and 4 were with intermediate values compared to control group and group 2. During phase 1, group 4 7 dysplayed fastest T hr and T chr . In another hand, group 2 showed a faster relaxation compared to controls, while the contractions from group 3 were with the longest relaxation.
Regarding time-parameters of AVP-provoked SMCs, the preparations from phase 1 developed contractions with similar T hc and T c with the exception of group 4 (Table 1) .
UH preparations from group 3 had contractions with prolonged T hr and T chr . Group 2 and 4 had fastest relaxation. During phase 2 only contractions of preparations from group 4 were with significantly different parameters compared to the other groups.
Other parameters
During the experimental period, no change in the blood pressure of the diabetic animals was found with exception of group 3 which was with statistically higher values.
Regarding body weight, the control group increased their mass with 40g, while group 2 lost about 75g. The animals from group 3 and 4 kept their body weight ( Table 2 ).
The analysis of blood sugar levels revealed that group 3 and 4 had lower plasma glucose levels than group 2 but at the same time these levels were significantly higher when compared to the controls. Such similarities were observed with HbA1c levels: in diabetic animals they were twice times higher than the controls, while group 3 and 4 had intermediate position (Table 3) .
Discussion
The experimentally induced DM influenced negatively the peptide-mediated uterine contractile activity. The chronic hyperglycemia affected equally the power characteristics of Ang II-and AVP-provoked responses. These disorders were probably due to the neuropathy, the damage of the pacemaker cells, and the myopathy caused by prove that the paradoxical vasodilator effect of AVP in brain and kidney vessels is due to NO synthesis by endothelial cells. It is reasonable to believe that during phase 2 NO synthesis is strongly influenced, while during phase 1 the produced NO, as a consequence of hypertrophy, leads to much faster relaxation of smooth musculature.
In addition, the found changes in body weight, plasma levels of glucose and The study of glycemic parameters also indicated a protective effect of MLT on B-cell function. These results are supported by a number of authors (Montilla et al. 1998; Guven et al., 2006) . The powerful antioxidant effect of MLT is considered to be the main factor that reduces cell death and apoptosis, caused by STZ. In addition, MLT decreases the expression of GLUT2 transporters, thus preventing STZ entrance in B-cells, which is evident by the improved glycemic profile and preserved body mass of experimental animals. The rapid achievement of T c and the development of very fast relaxation in Ang IIand AVP-mediated contractions of preparations from group 4 may be due to a direct effect of GHR on the smooth muscle tone. According to Qiu et al. (2008) and Asakawa et al. (2001) , in experimentally induced diabetes followed by administration of GHR, an increased spontaneous activity was registered, due to the activation of peripheral cholinergic pathways.
Conclusion:
Experimentally induced DM had a pronounced negative effect on the development of Ang II-and AVP-stimulated uterine SMCs, leading to reduced smooth muscle activity probably due to formation and accumulation of glycated products and ROS. The seven-day administration of MLT (10 mg/kg) or GHR (100 g/kg) had a beneficial effect on diabetic animals and partially improved the response of UH preparations to Ang II and AVP by reducing ROS, protein glycation and partial regeneration of the pancreas. MLT has primary antioxidant effect, while GHR possess reparative properties. Both hormones have a direct 11 effect on the development of SMC. The application of MLT in diabetic animals increased both force and time-parameters of Ang II-and AVP-stimulated uterine contractions while tretament with GHR increased power characteristics and shortened contraction and relaxation of the smooth muscle process. 
